Evidence map›Paper›PMID 35473910›Full record

ArticleNPJ systems biology and applications2022

Network- and enrichment-based inference of phenotypes and targets from large-scale disease maps.

Matti Hoch, Suchi Smita, Konstantin Cesnulevicius, David Lescheid, Myron Schultz, Olaf Wolkenhauer, Shailendra Gupta

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in nutrition · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matti HochDepartment of Systems Biology and Bioinformatics, University of Rostock, 18055, Rostock, Germany.ORCID 0000-0002-2486-0246
Suchi SmitaDepartment of Systems Biology and Bioinformatics, University of Rostock, 18055, Rostock, Germany.
Konstantin CesnuleviciusHeel GmbH, 76532, Baden-Baden, Germany.ORCID 0000-0003-4627-056X
David LescheidHeel GmbH, 76532, Baden-Baden, Germany.
Myron SchultzHeel GmbH, 76532, Baden-Baden, Germany.
Olaf WolkenhauerDepartment of Systems Biology and Bioinformatics, University of Rostock, 18055, Rostock, Germany. olaf.wolkenhauer@uni-rostock.de.ORCID 0000-0001-6105-2937
Shailendra GuptaDepartment of Systems Biology and Bioinformatics, University of Rostock, 18055, Rostock, Germany.ORCID 0000-0002-3470-3260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex diseases are inherently multifaceted, and the associated data are often heterogeneous, making linking interactions across genes, metabolites, RNA, proteins, cellular functions, and clinically relevant phenotypes a high-priority challenge. Disease maps have emerged as knowledge bases that capture molecular interactions, disease-related processes, and disease phenotypes with standardized representations in large-scale molecular interaction maps. Various tools are available for disease map analysis, but an intuitive solution to perform in silico experiments on the maps in a wide range of contexts and analyze high-dimensional data is currently missing. To this end, we introduce a two-dimensional enrichment analysis (2DEA) approach to infer downstream and upstream elements through the statistical association of network topology parameters and fold changes from molecular perturbations. We implemented our approach in a plugin suite for the MINERVA platform, providing an environment where experimental data can be mapped onto a disease map and predict potential regulatory interactions through an intuitive graphical user interface. We show several workflows using this approach and analyze two RNA-seq datasets in the Atlas of Inflammation Resolution (AIR) to identify enriched downstream processes and upstream transcription factors. Our work improves the usability of disease maps and increases their functionality by facilitating multi-omics data integration and exploration.

Indexed as

ProteinsPhenotypeProteins

Identifiers

PMID35473910
PMCPMC9042890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.